Jeroen Dekervel
机构：Universitair Ziekenhuis Leuven, KU Leuven · ORCID：0000-0001-7208-3480
发表论文 195 篇 · 总被引 3616 次 · h-index 24
代表论文
- A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 2)
- Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review (2026 · European Journal of Surgical Oncology · 被引 1)
- Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab (2026 · Targeted Oncology · 被引 1)
- Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS) (2026 · The Lancet Oncology)
- Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients (2026 · European Journal of Nuclear Medicine and Molecular Imaging)
- Young onset rectal cancer (YORC): a descriptive tertiary center analysis (2026 · European Journal of Surgical Oncology)